The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Hey Sam. You need to be realistic about your 1p target. I know you want/need it quickly but reality is even with amazing, blockbuster, excellent news it would take a few days of trading to see that rise, then along the way PI’s would be selling into that rise (esp at .9). I really think it’s a longer journey than you want it to be. GL
Hate to do this to y'all but this has been yet another pump and dump exercise using CTEA as the football. Due to the management's lack of interaction or even interest in Pi's, the rumour mongers can flourish.
Here are some alternative points to consider:
The company has not managed to secure any confirmed sales since it finished the app back in the early summer. It has announced a couple of JV's but these are heavily caveated that they may not lead to revenue.
BHA does not appear to have exclusive distribution of the Healgen test in the UK, only the Antai triple antibody test. (Read the BHA website carefully. They are only promoting and selling the Antai test, but they can (like others) supply the Healgen test)
Any covid passport app can only tell you the status of that individual when they were last tested. Due to the highly infectious nature of Covid, this is not much use to the general public. In the scenarios where it is of use (e.g. airlines) CTEA have had no sales.
CTEA have very few employees (4?) and don't own the bulk of the IP.
The Tweet from William the Conqueror that kicked off the rise (E-mail from BHA about sales) is HIGHLY suspect. (Jpeg artifacts on signature but not on text)
Check the dates on the recent RNS's and ask yourself if you can invest in a company that has produced so little information for its investors in a fast-moving market such as Covid.
There are some positives - its a good idea in the long term for non-covid uses. It has its uses in corporate scenarios. Personally the management team have shown no ability to move fast, capitalise on opportunities or treat PI's well. I got out a while ago. Please do your own research. My motives are just to stop people losing more money than they already have.
Yup Media Banca is a good candidate. "Mediobanca is a specialised financial group, whose business model is based on synergic, high profit margin and low capital intensity business sectors"
Also has around 70bn in assets as per last RNS.
When the MOU with UAE was announced it took a couple of days for the SP to rise, but when it did it was significant. I believe this was because there is a delay between the RNS and the resultant media coverage across the Arab world. So I can see this rising steadily over next few days once it gets into the press over there.
We know that AZ does pay a lot of attention to the PI's. More than he should, but forgive him he is an entrepreneur who is grateful that people would put their money into his company. There has been a lot of talk on boards and social media about Stormharbour news 'promised' at end of October. This puts AZ in a bind.
He effectively dealt with StormHarbour in the last relevant RNS but the message appeared to have been missed by most. To AZ if he puts out nothing it looks like he is breaking a promise - which he knows undermines the share and the trust in all the work he is doing. So he puts out something today that explains further about the exact situation with SH and the captive bank.
That's why its not perceived as being anything new. It really isn't, but it meets a need to keep a perceived promise.
My own thought is that today's RNS does not preclude a major update in the next week or two when the bank is officially named and we get a trading update on UK and ME.
I'm still holding. Nothing has changed.
@chuck
This is the nature of start-ups though. There is a lot of rapid movement around setting up the foundations of the service. AZ is in a no-win situation here. If he says nothing except numbers and contracts, the Investors get nervous. He is now trying to strike a balance between being judicious with his updates, but keeping investors informed and showing the direction of travel.
I doubt you will get the approach you outlined til at least 1 full year of the service being up and running.
It wasn’t a clinical trial. It was them trialling a reseller deal with Afrik-ID. Deal expires at end of October. If it had led to sales, an RNS would already have been issued.
No. You are not right.